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Summary
Reasons for performing study: Buprenorphine, a l-agonist opioid, has recently been licensed for equine use, but butorphanol, a j-agonist opioid, is
more commonly used in horses. The effect of the 2 opioids has not previously been compared in a large clinical study.
Objectives: To compare post operative analgesia and physiological variables in horses undergoing elective surgery following premedication with either
buprenorphine or butorphanol in a conventional clinical setting.
Study design: Multicentre, prospective, randomised, blinded clinical investigation.
Methods: Eighty-nine healthy horses admitted for elective surgery to one of 6 UK equine veterinary clinics were premedicated with acepromazine, a
nonsteroidal anti-inflammatory drug, and romifidine followed by intravenous (i.v.) buprenorphine or butorphanol. Anaesthesia was induced with
diazepam/ketamine and maintained with isoflurane in oxygen. A range of surgical procedures were performed and supplementary anaesthetic agents
given as required. Physiological variables were monitored during anaesthesia and pain, ataxia, sedation and vital function were assessed post
operatively. Data were analysed using t-tests, ANOVA, Mann–Whitney U-test and Chi-squared test as appropriate and P<0.05 was regarded as
significant, except for multiple comparisons, when P<0.01 was used.
Results: Surgery was carried out successfully in all cases and no mortality or serious morbidity occurred. Physiological variables remained within
normal limits and all horses recovered successfully, most standing within 1 h of ceasing anaesthesia. There were no significant differences between
groups in any variable except post operative pain when scores (simple descriptive scale) between 3 and 6 h were significantly lower after
buprenorphine than after butorphanol.
Conclusions: Horses experienced less post operative pain after buprenorphine than after butorphanol premedication. Compared with butorphanol,
buprenorphine did not cause any different effects on vital function.
Keywords: horse; general anaesthesia; buprenorphine; butorphanol; opioid
Introduction
It is now widely accepted that horses should receive perioperative
analgesia in the same way as other species [1]. Opioids are often used to
provide perioperative analgesia in small animals and man, as they are not
only effective analgesics but also contribute to balanced anaesthesia by
providing intrinsic analgesia during surgery. Opioids have been used to
enhance sedation for many years [2,3] but there is still some reluctance for
their perioperative use in horses, leading to over-reliance on nonsteroidal
anti-inflammatory drugs (NSAIDs) [4,5]. Opioids are often withheld in horses
because of fear of locomotor stimulation and depression of intestinal
motility [4,6]. Much evidence comes from studies of high doses in healthy
research horses; opioids are less likely to cause side effects in animals
experiencing clinical pain [7]. Several studies investigating perioperative
opioid use in horses have not shown an increased incidence of adverse
events [8–10], suggesting that opioids could be more widely used for
perioperative analgesia in horses.
It is generally accepted that l opioid receptor agonists provide the best
analgesia. However, butorphanol, a j agonist, is still most commonly used
in horses to provide analgesia and enhance sedation, although it is often
regarded as a relatively ineffective analgesic. Butorphanol did not produce
better post castration pain control than placebo [11], while in contrast
buprenorphine, a partial l agonist, was superior to both butorphanol [12]
and placebo [13]. Although morphine and methadone, pure l agonists,
would be expected to provide the best opiate analgesia and are quite
commonly used in horses, they do not have appropriate UK market
authorisation and there are no published clinical studies investigating the
analgesic effect of systemic methadone or morphine in horses undergoing
general anaesthesia for surgery. Buprenorphine has recently received UK
market authorisation for analgesia and enhancement of sedation in horses,
and its potential contribution to clinical equine anaesthesia requires
evaluation. The hypothesis of this investigation was that buprenorphine
would provide better post operative analgesia than butorphanol. The aim
of the investigation was to compare the degree of post operative pain
experienced by horses after elective surgery following premedication with
either buprenorphine or butorphanol in a conventional clinical setting. A
subsidiary aim was to evaluate any differences in physiological variables
and other drug requirements.
Materials and methods
The study was originally approved under Animal Test Certificate No. 14094/
0006 and informed consent was obtained from the owner of each horse.
Market authorisation for buprenorphine as Vetergesic Multidosea was
granted and ATC requirements relaxed during the course of investigation.
Thereafter, restriction on the inclusion of common supplementary drugs
such as NSAIDs and local anaesthetics was lifted.
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Horses
Horses admitted for elective surgery under general anaesthesia to
one of 6 UK equine veterinary clinics were recruited. Horses over
6 months of age graded ASA 1 or 2 under the American Society of
Anesthesiologists physical status classification system were eligible for
inclusion (https://www.asahq.org/resources/clinical-information/asa-
physical-status-classification-system). Exclusion criteria were hepatic,
abdominal, respiratory or cardiac disease, pregnancy or lactation, and
treatment with analgesics, respiratory depressants, high sedative
doses or sympathomimetic amines within the previous 7 days.
Premedication and induction of anaesthesia
All animals were premedicated according to the protocol normally used
in the participating clinic. This usually incorporated intravenous (i.v.)
acepromazine (0.02–0.03 mg/kg bodyweight [bwt]) approximately 1 h
before placement of a jugular venous catheter and induction of
anaesthesia. Induction was preceded by an alpha2 adrenoceptor agonist
(alpha2 agent) (romifidine 0.08 mg/kg bwt or detomidine 0.01 mg/kg bwt)
given i.v. followed immediately by either buprenorphine (Vetergesic
Multidose)a, (group BN, 5–10 lg/kg bwt) or butorphanol (Torbugesic)b
(group BT, 0.02–0.1 mg/kg bwt) given i.v. according to a randomised
treatment chart allocated to each clinic. The assessor (usually
the anaesthetist) was blinded and unaware of the identity of the opioid.
The test drug was allocated and drawn up by another clinician, the
‘administrator’. Blinding was completed either by adding saline to the
syringe of butorphanol immediately prior to injection so that the test
drugs’ volumes were the same, or by the administrator giving the
injection. Anaesthesia was induced according to the normal clinic
protocol, generally with i.v. ketamine (2–3 mg/kg bwt) and diazepam
(0.04–0.06 mg/kg bwt). The quality of sedation after the opioid had been
given and the quality of induction were scored on a 4-point simple
descriptive scale (SDS) (Table 1).
Maintenance of anaesthesia
After induction, the trachea was intubated and anaesthesia maintained
with a volatile agent, usually isoflurane, vaporised in oxygen. Horses were
allowed to breathe spontaneously or ventilated to prevent hypercapnia,
following the usual practice of each clinic. Routine monitoring included
heart rate (HR), respiratory rate (RR), mucous membrane colour (pink,
pale, cyanotic) and invasive arterial blood pressure (ABP), usually
measured in the facial artery. End-tidal anaesthetic agent concentration
(ETiso) and carbon dioxide partial pressure (ETCO2) (side stream infrared
absorption) were also measured in clinics possessing appropriate
equipment. Dobutamine was infused i.v. to provide cardiovascular
support as indicated by mean APB (MABP). Surgery was carried out
according to the clinic’s own protocol; the quality of the surgical
conditions was scored by the surgeon, unaware of treatment allocation
(Table 1). After surgery, horses were allowed to recover under
observation, normally in a padded recovery box; sedation and assistance
were given, if necessary. Additional drugs including antibiotics, NSAIDs,
inotropes, crystalloids, local anaesthetics and additional alpha2 agents,
benzodiazepines, ketamine and thiopental were given according to
practice routine and recorded.
Recovery and post operative period
The time intervals between premedication and induction of anaesthesia,
duration of anaesthesia and time to recovery (from ceasing the volatile
anaesthetic administration to first movement, first attaining sternal and first
standing) were recorded. The quality of recovery was scored and post
operative pain, sedation and ataxia were assessed 1, 2, 3, 4, 5, 6 and 24 h
after anaesthesia using a 4-point SDS (Table 1). Any horse deemed in
unacceptable pain (SDS>1) at any time after surgery was given 10 lg/kg
bwt buprenorphine i.v. If still in unacceptable pain 30 or more min later, an
NSAID or other treatment deemed appropriate by the clinician was given
i.v. and recorded. Intestinal activity was assessed post operatively by
auscultation of the abdomen and noting faecal production. Any adverse
events were documented. A single person performed all assessments for
an individual horse.
Data analysis
The data from horses in the BN group were compared with those in the BT
group. The primary outcome measure was post operative pain score, with
a null hypothesis that there would be no differences between the groups.
Secondary outcome measures were perioperative physiological variables
and post operative sedation and ataxia, with a null hypothesis of no
differences between groups.
Data from all horses were used in the statistical analysis as virtually all
horses received acepromazine, romifidine, ketamine, diazepam and
isoflurane. Detomidine substitution for romifidine, midazolam for
diazepam and sevoflurane or halothane for isoflurane in a few horses
was deemed unlikely materially to affect the results, since these
substitutions were all similarly acting drugs from the same drug group
and occurred equally in BN and BT. A few missing data points occurred
throughout data collection but were both low in number and equally
spread between the groups, and therefore were considered unlikely to
affect the results.
Single measurements of continuous variables were compared using
unpaired t-tests (bwt, age, drug doses and time periods). Non-normally
distributed data were compared using the Mann–Whitney U-test (all SDS),
Chi-squared test (sex, breed and surgical procedure) or Fisher’s exact test
(dichotomous data). Continuous data collected over time were analysed
using repeated measures ANOVA followed by Tukeys’ multiple
comparisons test, if appropriate (HR, RR, ABP, ETCO2 and ETiso). For
statistical purposes, SDS pain scores in animals requiring rescue analgesia
TABLE 1: Simple descriptive scales for sedation, induction and
recovery quality, surgical conditions, ataxia and pain
Variable Score and description
Sedation (0) Fully conscious
(1) Reduced response to local activity
(2) Standing, ataxic, uncaring about stimulation from
handling
(3) Very ataxic, would fall if moved, oblivious to local
surroundings
Induction
quality
(0) Ataxic, barely becomes recumbent, danger of injury
to horse and handler
(1) Goes down but considerable staggering
(2) Goes down easily, but some staggering and poor
relaxation initially
(3) Goes down perfectly
Surgical
conditions
(0) Impossible to perform surgery
(1) Surgery performed with difficulty
(2) Surgery performed adequately, but not fully relaxed
(3) Surgery performed easily on well relaxed animal
Recovery
quality
(0) Violent and ataxic, numerous attempts to stand
(1) Ataxic, numerous attempts to stand
(2) Stands up with minimal ataxia, a few attempts to stand
(3) Stands perfectly at first attempt
Ataxia (0) No ataxia. Horse stands and walks normally; is able to
turn tightly
(1) Mild ataxia. Horse able to walk, but some lack of limb
control
(2) Moderate ataxia. Horse can walk only with support,
staggers but saves itself from falling
(3) Marked ataxia. Horse is unable to walk without danger
of falling, staggers, falls if turned
Pain (0) Normal behaviour, eating, alert, interactive
(1) A little subdued, eats intermittently, a little
apprehensive about interaction
(2) Subdued, walks stiffly, occasional snatch at food only,
does not interact willingly
(3) Very stiff gait, does not eat, glancing at surgical site,
may roll, does not interact at all
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were taken as the score awarded at rescue until the end of the assessment
period (LOCF). Data are presented as mean  s.d. unless otherwise stated;
P<0.05 was regarded as significant except for multiple comparisons where
P<0.01 was used.
One clinic, which anaesthetised almost half of the horses, consistently
used the lowest dose of both buprenorphine (5 lg/kg bwt) and
butorphanol (0.02 mg/kg bwt) (low dose), whereas the remaining clinics
used nearer 10 lg/kg bwt and 0.1 mg/kg bwt, respectively (high dose).
Subsidiary statistical analyses were performed to evaluate potential
effects of the different doses by comparing these 2 subsets within each
group.
Based on previous studies [11,13], 50 animals per group were required
to give 80% power to detect a 25% difference in the proportion of animals
in each group with post operative pain scores of 0 or 1. Smaller differences
were deemed unlikely to be of clinical significance. Interim power analysis
after 74 horses had been recruited indicated that 100 horses was more
than necessary and the investigation was completed with a further 15
cases.
Results
Horses details, premedication and anaesthesia
Eighty-nine horses were recruited (Table 2). The vast majority received
acepromazine i.v. approximately 1 h before romifidine and the test
opioid were given; most also received an NSAID i.v. (Table 2) and
antibiotics i.v. or intramuscularly (i.m.). Oral trimethoprim-sulphonamide
was given several hours before anaesthesia in one clinic. There were no
differences between the groups in the proportion of animals treated with
each antibiotic protocol (P>0.5). All horses were clearly sedated
immediately prior to induction after the a2 agent and opioid had been
given; most horses in both groups scored 2 and there were no sedation
scores of 0 (Table 2). Higher opioid doses were associated with deeper
sedation and a few horses in each group were noted to be very ataxic
with the heavy sedation (Table 2). Anaesthesia was induced
approximately 5 min after the opioid injection with diazepam and
ketamine. The median induction score in BN was higher than in BT, but
the difference did not reach significance owing to a single score 0
induction in the BN group (Table 2). The dose of opioid (low or high) did
not affect any premedication/induction results except for sedation score
(all P>0.05).
Maintenance of anaesthesia
Anaesthesia was maintained with isoflurane and mechanical ventilation in
the vast majority of horses (Table 2). Respiratory rate decreased below
conscious values during anaesthesia in all spontaneously breathing horses.
In the ventilated horses, no intergroup differences were detected in
selected rate, ETCO2 or ETiso (Table 2). Dobutamine was administered in
most horses and MABP was maintained above 65 mmHg in all except one,
where it decreased briefly to 55 mmHg (Tables 2, 3). Persistent
hypertension did not occur; MABP transiently reached 100–105 mmHg in
only a few cases. All horses received crystalloid solutions. Mucous
membranes were recorded as pink in all horses except for one in BN that
was pale (P = 0.5). No cyanotic mucous membranes were noted.
Anaesthesia lasted around 1.5 h in both groups (Table 2) and surgical
conditions were excellent (score 3) in over 80% of horses in both groups
(P = 0.5). The dose of opioid (low or high) did not affect any results relating
to maintenance of anaesthesia (all P>0.05).
Recovery and post operative period
An elective a2 agent was given i.v. to half of the horses in both groups
when they were moved into the recovery box (Table 2). Most horses stood
in less than 1 h and quality was score 3 in over a third of both groups.
There were no significant group differences in quality or duration (Table 2)
and results were unaffected by the dose of opioid (low or high) (all P>0.05).
Heart and respiratory rates remained within normal limits post operatively
and there were no intergroup differences. The dose of opioid (low or high)
did not affect either HR or RR post operatively (all P>0.05).
Most horses received a preoperative pain score of 0. A few in each
group scored 1 owing to mild lameness of the limb scheduled to undergo
surgery (P = 0.6). Post operative pain scores were significantly lower in BN
than BT from 3 until 6 h post operatively (Fig 1). Rescue analgesia was
given 8.2  6.4 and 8.1  6.3 h (P>0.9), respectively after opioid
administration in 5 BN and 11 BT horses (P = 0.2). Of these, 3 BN and 6 BT
horses had been premedicated with the low opioid dose (buprenorphine
5 lg/kg bwt; butorphanol 0.02 mg/kg bwt). In all 16 cases rescue analgesia
with buprenorphine (7.5–10 lg/kg bwt) was successful, resulting in much
more comfortable horses. One horse in BT received phenylbutazone which
was also effective. One BN and 5 BT horses required more analgesic
treatment and were given a NSAID after a further 12 and 3.2  2.3 h,
respectively. This second treatment was effective in all cases. Three horses
in BN were given NSAID in the evening after soft tissue surgery, although
their pain scores were all 0.
All sedation and ataxia scores were 0 before anaesthesia. Both sedation
and ataxia were evident 1 h post anaesthesia in both groups when a few
horses in each group were still recumbent. Thereafter, sedation and ataxia
abated and the median score for both variables was 0 in both groups
(Table 2). A couple of horses in each group were still mildly sedated
(score 1) at 4 h and mildly ataxic until 5–6 h but all scored 0 by 6 h except
for 2 in BN of which one had been given acepromazine post operatively
(Table 3). There was no difference between the groups post operatively in
either sedation or ataxia (Table 2).
Adverse effects
No animals died or suffered any significant perioperative morbidity. Mild
box walking and post operative colic occurred in very few horses in either
group (Table 3). Box walking could be controlled by normal head restraint
and was not extreme.
Discussion
The investigation fulfilled the aim of comparing the effects of
buprenorphine and butorphanol premedication under conventional UK
equine anaesthetic clinical practice. The hypothesis that buprenorphine
would provide better post operative pain control than butorphanol was
supported.
The study was intended to compare the 2 opioids under conditions
representing normal UK equine veterinary practice. As a result, a range of
anaesthetic protocols, surgical procedures and types of horse were
included. The range was equally represented in both groups and the
results should be free from bias and applicable to many scenarios
encountered in equine practice. In order to retain a normal clinical setting,
where a single dose of opioid is commonly used to enhance sedation, no
allowance such as repeat dosing was made for butorphanol’s shorter
duration of action than that of buprenorphine [14]. The longer lasting post
operative effect of buprenorphine in this study is consistent with
experimental data.
The dose range of each opioid was intended to be equivalent and
based on the respective datasheet. Buprenorphine recommendations
(5–10 lg/kg bwt) were derived from laboratory studies using acute
nociceptive threshold testing [14] where comparison was made with a
single dose of butorphanol. The datasheet dose range for butorphanol
(0.025–0.1 mg/kg bwt) is more historical, but the full range is used
clinically.
The drugs used for anaesthesia were consistent throughout the study,
with acepromazine, romifidine, ketamine, diazepam and isoflurane being
used almost exclusively. This appears to reflect a widespread perception
that this is the most common protocol currently used in the UK. Data from
the few cases receiving alternatives to the regular drugs were included in
the analysis as they were equally distributed between groups and only
formed a small minority. Replacement drugs were always of the same
type that should have a similar effect. For instance, romifidine was
replaced with detomidine; both are a2 agents used almost
interchangeably in horses. Detomidine is slightly shorter acting and may
result in more ataxia in a conscious horse [15] and slightly less
hypotension during anaesthesia [16], but in all other respects have similar
effects. Diazepam was replaced by midazolam on a few occasions. These
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TABLE 2: Horse details, drug administration and perianaesthetic data in 89 horses premedicated with either intravenous buprenorphine or
butorphanol before surgery under general anaesthesia
Variable
BN: buprenorphine
n = 43
BT: butorphanol
n = 46
Between group
comparison
Bodyweight (bwt) (mean  s.d.) 514  116 kg 522  141 kg t test
P = 0.8
Age (mean  s.d.) 8.5  4.8 years 8.0  4.4 years t test
P = 0.6
Sex 12 Female (28%)
19 Gelding (44%)
12 Entire male (28%)
12 Female (26%)
25 Gelding (54%)
9 Entire male (20%)
Chi-square
P = 0.6
Breed 14 Thoroughbred
11 Warmblood
5 Sport horse
5 Cob
5 Pony
3 Other
12 Thoroughbred
10 Warmblood
10 Sport horse
5 Cob
3 Pony
6 Other
Chi-square
P = 0.3
Surgery 8 ENT
26 Ortho
4 Castration
5 Superficial
9 ENT
28 Ortho
5 Castration
4 Superficial
Chi-square
P>0.9
Acepromazine 0.03  0.004 mg/kg bwt (n = 42)
1 horse none
0.03  0.006 mg/kg bwt t test
P = 0.6
Alpha2 agent Romifidine (n = 37)
0.08  0.01 mg/kg bwt
Detomidine (n = 6)
0.01  0 mg/kg bwt
Romifidine (n = 43)
0.08  0.01 mg/kg bwt
Detomidine (n = 3)
0.01  0 mg/kg bwt
t test
P = 0.3
Opioid dose High 9.7  1.0 lg/kg bwt (n = 24)
Low 5.0  0.02 lg/kg bwt (n = 19)
Mean 7.6  2.5 lg/kg bwt
High 0.08  0.04 mg/kg bwt (n = 25)
Low 0.03  0.02 mg/kg bwt (n = 21)
Mean 0.06  0.04 mg/kg bwt
Diazepam 0.05  0.02 mg/kg bwt (n = 42)
1 horse midazolam
0.05  0.01 mg/kg bwt t test
P = 0.3
Ketamine (induction) 2.3  0.2 mg/kg bwt 2.3  0.2 mg/kg bwt t test
P = 0.8
Time acepromazine to induction 66  27 min 73  32 min t test
P = 0.3
Time opioid to induction 8  5 min (median 5 min) 10  10 min
(median 5 min)
t test
P = 0.2
Anaesthesia Isoflurane (n = 39)
Halothane (n = 3)
Sevoflurane (n = 1)
Isoflurane (n = 44)
Halothane (n = 2)
Fisher’s exact
P = 0.4
Ventilation mode IPPV (n = 36) (84%) IPPV n = 36 (78%) Fisher’s exact
P = 0.6
Dobutamine infusion 33 horses (77%) 35 horses (76%) Fisher’s exact
P>0.9
NSAID premedication Flunixin n = 27 (63%)
Phenylbutazone n = 10 (23%)
Flunixin n = 30 (65%)
Phenylbutazone n = 10 (22%)
Chi-square
P = 0.7
Supplementary anaesthesia 23 horses (53%) 25 horses (54%) Chi-square
P>0.9
Alpha2 agent for recovery Romifidine n = 15 (35%)
Xylazine n = 9 (21%)
Romifidine n = 14 (30%)
Xylazine n = 5 (11%)
Chi-square
P = 0.3
Sedation quality before induction – all horses Median score 2
Score 2 n = 31 (74%)
Median score 2
Score 2, n = 33 (73%)
MWU
P = 0.6
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TABLE 2: (Continued)
Variable
BN: buprenorphine
n = 43
BT: butorphanol
n = 46
Between group
comparison
Sedation quality
high and low dose effect
High: score 3, n = 8 (33%)
Low: score 3, n = 0 (P < 0.001)
High: score 3, n = 10 (42%)
Low: score 3, n = 0
(P<0.001)
Chi-square
P = 0.8
Induction quality Median score 3
Score 3, n = 28 (65%)
Median score 2
Score 3, n = 20 (43%)
MWU
P = 0.05
HR: premean  s.d.
(range of mean per horse during anaesthesia)
Pre 36  4 beats/min
(33–35 beats/min)
Pre 36  5 beats/min
(33–35 beats/min)
2-way ANOVA
P = 0.8
RR: premean  s.d.
(spontaneous: range of mean per horse
during anaesthesia)
13  2 per min
(5–6 per min) n = 7
12  3 per min
(5–6 per min) n = 9
t test
P = 0.07
ETCO2 (ventilated horses)
(range of mean per horse during anaesthesia)
(5.7–6.1 kPa) n = 9 (5.5–6.0 kPa) n = 40 2-way ANOVA
P = 0.3
MABP (range of mean per horse
during anaesthesia)
25 min: 65  10 mmHg
60 min: 70  12 mmHg
(increase P<0.001)
25 min: 67  11 mmHg
60 min: 72  9 mmHg
(increase P<0.001)
2-way ANOVA
P = 0.6
ETiso
(range of mean per horse
during anaesthesia)
n = 26
5 min: 1.1  0.4%
60 min: 1.3  0.3%
(increase P<0.001)
n = 29
5 min: 1.1  0.4
60 min: 1.3  0.2%
(increase P<0.001)
2-way ANOVA
P = 0.5
Duration of anaesthesia 102  44 min 91  38 min t test
P = 0.2
Recovery quality Median score 2
Score 3 n = 19 (44%)
Score 2 n = 17 (40%)
Score 1 n = 6 (14%)
Score 0 n = 1
Median score 2
Score 3 n = 16 (35%)
Score 2 n = 18 (39%)
Score 1 n = 11 (24%)
Score 0 n = 1
MWU
P = 0.4
Recovery time to 1st move 23  11 min 25  12 min P = 0.4
Recovery time to sternal 29  16 min 29  13 min P>0.9
Recovery time to stand 36  18 min 35  14 min P = 0.8
Post operative HR 1 h: 41  12 beats/min
24 h: 39  6 beats/min
(decrease P<0.001)
1 h: 38  6 beats/min
24 h: 36  6 beats/min
(decrease P<0.001)
2-way ANOVA
P = 0.1
Post operative RR 1 h: 14  5 breaths/min
24 h: 12  4 breaths/min
(decrease P < 0.001)
1 h: 14  7 breaths/min
24 h: 12  5 breaths/min
(decrease P<0.001)
2-way ANOVA
P = 0.2
Post operative sedation 1 h: median score 1
2 h: median score 0
24 h: median score 0
1 h: median score 1
2 h: median score 0
24 h: median score 0
MWU
P = 0.6 (1 h)
P>0.9 (24 h)
Post operative ataxia 1 h: median score 1
2 h: median score 0
24 h: median score 0
1 h: median score 1
2 h: median score 0
24 h: median score 0
MWU
P = 0.4 (1 h)
P>0.9 (24 h)
Breed: Other = Arab, Andalusian, Shire, Quarter Horse.
Surgery: ENT = tieback, tie forward, Hobday, soft palate cautery and eye surgery.
Ortho = orthopaedic procedures including neurectomy, splint bone debridement, tooth extraction and desmotomy. Castration includes
cryptorchidectomy.
Superficial = skin mass removal and hernia repair.
Supplementary anaesthesia: 1 or 2 ketamine doses (0.1–0.3 mg/kg bwt), thiopentone (0.5–1 mg/kg bwt), benzodiazepine with ketamine (0.05–0.2 mg/kg
bwt) as a single bolus, local anaesthetic block of the surgical site, intra-articular local anaesthetic or morphine, a2 agent or ketamine infusion.
HR, heart rate; RR, respiratory rate; ETCO2, end-tidal carbon dioxide tension; MABP, mean arterial blood pressure; ETiso, end-tidal isoflurane concentration.
No significant differences between groups.
Pre, before any drugs administered; MWU, Mann–Whitney U-test.
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are both benzodiazepines of similar duration of effect in horses and have
been shown to be indistinguishable when used with ketamine for
induction prior to surgery for castration [17]. Ketamine was used
exclusively for induction, demonstrating its recent almost universal
adoption for this purpose in horses. Isoflurane was used almost
exclusively for maintenance of anaesthesia. Moreover, all volatile
anaesthetic agents cause cardiorespiratory depression in horses, and
isoflurane and sevoflurane are similar in this respect; although halothane
causes greater reduction in cardiac output, the effect on ABP is similar.
The surgical procedures were elective, covering those routinely
undertaken in equine practice. Since emergency surgery was not
included, neither major trauma repair nor colic surgery were included.
Most procedures covered in this study would probably produce only
mild to moderate pain and the hypothesis was not tested under
extreme conditions. However, a significant difference between the 2
opioids was demonstrated even when the expected degree of pain
was not severe, underlining the belief, supported by the power
calculations, that the study was appropriate for comparing the
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Fig 1: Post operative SDS (0–3) pain scores in 89 horses premedicated with either buprenorphine (n = 43) group BN or butorphanol (n = 46) group BT before surgery
under general anaesthesia. The proportion of the group awarded each score is shown. Significantly more horses received lower scores in BN than BT. *Denotes
significant difference between groups:1 h P = 0.9 NSD, 2 h P = 0.2 NSD, 3 h P < 0.001*, 4 h P < 0.001*, 5 h P < 0.001*, 6 h P = 0.01 NSD, 24 h P = 0.5 NSD.
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analgesic effect of the 2 drugs. It seems unlikely that butorphanol
would be sufficient for severe pain, and buprenorphine has yet to be
evaluated fully.
One clinic contributing almost half of the cases used lower doses of
both opioids than the other centres. Supplementary analysis of the two
subgroups, low (buprenorphine 5 lg/kg bwt, butorphanol 0.03 mg/kg
bwt) and high (buprenorphine 9.7 lg/kg bwt, butorphanol 0.08 mg/kg
bwt) doses in each of the BN and BT groups again demonstrated better
pain control with buprenorphine than butorphanol when the higher
doses were used, but there was no difference with the lower doses.
These comparisons were underpowered and may have failed to detect a
true difference with the lower doses. Comparison of the high and low
dose effects within each group did not reveal significant differences,
although there was a tendency towards better pain control in BN with
the higher dose. This comparison is of questionable validity, as it
compared data between different clinics and clinicians as well as being
underpowered. However, these results do indicate that even at lower
doses buprenorphine is the better analgesic, but appears most effective
at doses above 5 lg/kg bwt.
The cardiorespiratory effects of anaesthesia in both groups were
unremarkable and reflected the expected course of anaesthesia in horses.
Hypotension and respiratory depression are well recognised hazards and
the use of dobutamine and mechanical ventilation are well accepted in
routine equine anaesthesia [18]. The need for dobutamine support was
similar in the two groups, suggesting that neither opioid contributed to
substantially more cardiovascular depression than is normally encountered
during volatile agent anaesthesia in horses. Whether a horse was ventilated
or not depended more on the usual clinic protocol than a response to any
measure of respiratory depression, and too few horses breathed
spontaneously to allow evaluation of any differential effect of the 2 opioids
on respiration.
Isoflurane requirements and the need for supplementary anaesthetics
were unaffected by the opioid used. The latter contrasts with a recent
report of better surgical conditions and less requirement for
supplementary anaesthetic ‘top ups’ during castration under i.v.
anaesthesia after buprenorphine premedication (5 lg/kg bwt) compared
with butorphanol (12.5 lg/kg bwt) [12]. Volatile agent anaesthesia and
longer duration of surgery appeared to obliterate any potential
anaesthetic-sparing differences between the 2 opioids.
The incidence of adverse effects was low and overall treatment
successful in all horses. Subjectively, box walking appeared more
persistent with buprenorphine and occurred in 3 horses after rescue
analgesia with buprenorphine 10 lg/kg bwt. The data (Table 3) suggest
that the buprenorphine dose may be critical; 5 lg/kg bwt appears less
likely to cause locomotor activity but needs to be set against the better
pain relief from 10 lg/kg bwt. One horse box walked after 10 lg/kg bwt
but a subsequent dose of 7.5 lg/kg bwt provided pain relief without
locomotion. Evaluation of buprenorphine in horses under research
laboratory conditions has always reported some signs of excitement [19],
which may be dose related. Sedation was less effective when detomidine
(10 lg/kg bwt) was combined with buprenorphine 10 lg/kg bwt rather
than with 7.5 or 5 lg/kg bwt; 7.5 lg/kg bwt is perhaps the best
compromise [20]. Clutton [7] emphasises that the precise dose of opioids is
important and that they are less likely to cause side effects when used to
treat pain. Other sedative and anaesthetic drugs given during general
anaesthesia must also contribute and may have lessened box walking in
this series. A few published clinical studies using buprenorphine contribute
to this discussion. No locomotor stimulation was reported after
buprenorphine (6 lg/kg bwt) was given with a detomidine infusion for
laparoscopic surgery in standing horses [21]. However, more locomotor
activity after castration under i.v. anaesthesia was seen in ponies
premedicated with buprenorphine (5 lg/kg bwt) than butorphanol
(12.5 lg/kg bwt) [12]. Box walking was reported in 4/4 horses after
10 lg/kg bwt buprenorphine were given with a detomidine infusion for
standing dental surgery, in contrast to 0/4 which received morphine
(0.1 mg/kg bwt) [22]. Box walking was not reported in any of 46 horses
sedated with detomidine and buprenorphine receiving either 5 or 10 lg/kg
bwt [23]. The amount of buprenorphine at the effector site presumably
relates most closely to the likelihood of any opioid effects. Anaesthesia and
surgery themselves may affect how the administered dose reaches and is
TABLE 3: Post operative adverse effects in 89 horses premedicated with either intravenous buprenorphine or butorphanol before surgery
under general anaesthesia. There was no significant differences between groups
Box walking after recovery from anaesthesia
n BN: buprenorphine n = 4 n BT: butorphanol (2 horses) Fisher’s exact
P = 0.4240
3 Within 30 min of rescue analgesia with 10 lg/kg buprenorphine
1) Premed was 5 lg/kg bwt. Resolved spontaneously after 2 h.
A further 7.5 lg/kg after 12 h had no adverse effect.
2) Premed was 10 lg/kg bwt. Ceased after romifidine 6 lg/kg bwt
and butorphanol 8 lg/kg bwt.
3) Premed was 10 lg/kg bwt. Rescue given 4 h after premed.
Walking ceased after acepromazine 0.01 mg/kg bwt at 4 h.
1 5 h after premed
Premed was 0.02 mg/kg bwt. Resolved
spontaneously after 3 h Rescue analgesia
with buprenorphine
10 lg/kg bwt no effect on locomotor
activity
1 8 h after premed.
Premed 10 lg/kg bwt. Brief period of walking. Resolved
spontaneously
1 Started immediately after recovery.
Premed was 0.1 mg/kg bwt. Resolved
spontaneously in 1 h
Post operative colic
(1 horse) (2 horses) Fisher’s exact
P = 1
1 Mild impaction morning after surgery.
Premed was 10 lg/kg bwt. Resolved after oral fluid and
metamizole/butylscopolamine
1 Distended dorsal colon during night
after surgery. Premed was 0.1 mg/kg
bwt. Resolved after flunixin 1 mg/kg
bwt, buprenorphine 10 lg/kg bwt and
inhand walking exercise
-
Miscellaneous
(1 horse) (1 horse)
1 Prolonged mild sedation (7 h) after recovery from
cryptorchidectomy.
Normal thereafter
1 Hypotension during anaesthesia
(MABP 55–60 mmHg) unresponsive to
dobutamine. Normal recovery
n = number affected.
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sustained at the effector site. Both detomidine and butorphanol plasma
concentrations were lower in horses when the peripheral a2 antagonist
MK-467 was also administered [24]. Prevention of detomidine’s
cardiovascular effects with MK-467 probably enhances excretion of both
detomidine and of other drugs given concurrently, through better hepatic
drug delivery. If a2 agents lead to higher opioid plasma and effector site
concentration, particularly if sustained by infusion rather than a single
dose, enhanced and prolonged opioid effects may be inevitable. Further
investigation into dose, plasma concentration and effect relationships
should characterise appropriate buprenorphine dosage to provide the
optimal analgesia without side effects.
Decreased intestinal motility is a well known effect of opioids in horses
[25]. Previous investigations indicated that preoperative administration of
morphine, at least, was not associated with a greater incidence of colic
[10]. The present study supports this, reporting a similarly low incidence of
post operative colic and no association with either l- or j-agonist opioid
premedication. Numerous other characteristics of anaesthesia and surgery,
such as change in management, use of a2 agents, perioperative starvation
and pain, may predispose to altered intestinal function; all need to be
taken into consideration when selecting optimal management for horses
undergoing surgery.
In conclusion, buprenorphine (5–10 lg/kg bwt) resulted in better post
operative analgesia than butorphanol (0.03–0.1 mg/kg bwt) without
causing further physiological disruption than normally expected of general
anaesthesia in horses. Side effects were limited after both opioids but
efforts to refine the buprenorphine dose would be worthwhile to reduce
these further.
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